Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT05026177

Public ClinicalTrials.gov record NCT05026177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 76-week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects With Mild-to-Moderate Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 76-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease (AD) for 76 weeks. Approximately 1083 participants will be randomized (1:1:1) to receive either placebo, 50 mg tablets of simufilam, or 100 mg tablets of simufilam, twice daily, for 76 weeks. Clinic visits will occur 4 weeks after the baseline visit, and then every 12 weeks until the end of the study. The safety of simufilam, and its efficacy in enhancing cognition and slowing cognitive and functional decline will be evaluated.

Study identification

NCT ID
NCT05026177
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cassava Sciences, Inc.
Industry
Enrollment
1,125 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 87 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2021 (Actual)
Primary completion
Dec 30, 2024 (Actual)
Completion
Dec 30, 2024 (Actual)
Last update posted
Sep 22, 2025

2021 – 2024

United States locations

U.S. sites
65
U.S. states
19
U.S. cities
60
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona 85006 —
Arizona Neuroscience Research, LLC Phoenix Arizona 85032 —
Clinical Endpoints Scottsdale Arizona 85258 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
Banner Alzheimer's Institute - Tucson Tucson Arizona 85718 —
North County Neurology Associates Carlsbad California 92011 —
Neuro-Pain Medical Center Fresno California 93710 —
Neurology Center of North Orange County Fullerton California 92835 —
Healthy Brain Clinic Long Beach California 90804 —
California Research Insitute Los Angeles California 90027 —
Shankle Clinic and Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
Pacific Research Network, LLC San Diego California 92103 —
Nuvance Health Medical Practice CT, Inc. - Associated Neurologists, PC Danbury Connecticut 06810 —
Ki Health Partners, LLC Stamford Connecticut 06905 —
JEM Research Institute Atlantis Florida 33462 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
Clinical Research of Brandon, LLC Brandon Florida 33511 —
Quantum Laboratories Deerfield Beach Florida 33442 —
Brain Matters Research Inc Delray Beach Florida 33445 —
Indago Research and Health Center, Inc. Hialeah Florida 33012 —
Alphab Global Research Jupiter Florida 33458 —
K2 Medical Research Maitland Florida 32751 —
Mind Institute at Miami Jewish Health Miami Florida 33137 —
Brainstorm Research Miami Florida 33176 —
Health Synergy Clinical Research Okeechobee Florida 34972 —
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Orlando Florida 32801 —
Intercoastal Medical Group - Sarasota Sarasota Florida 34239 —
Alzheimer's Research & Treatment Center Stuart Florida 34997 —
Brain Matters Research Inc Stuart Florida 34997 —
USF Health - Byrd Alzheimer's Center and Research Institute Tampa Florida 33613 —
Alzheimer's Research & Treatment Center Wellington Florida 33414 —
Conquest Research Winter Park Florida 32789 —
Columbus Memory Center, PC Columbus Georgia 31909 —
Accel Research Sites - NeuroStudies Decatur Georgia 30030 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Advocate Aurora Health Park Ridge Illinois 60068 —
University of Kentucky Sanders-Brown Center on Aging Lexington Kentucky 40504 —
Neurology Center of New England Foxborough Massachusetts 02035 —
ActivMed Practices & Research, LLC Methuen Massachusetts 01844 —
Boston Center for Memory Newton Massachusetts 02459 —
Office of Donald S. Marks, M.D., P.C. Plymouth Massachusetts 02360 —
MedVadis Research Waltham Massachusetts 02451 —
Patient First MD Middletown New Jersey 07748 —
Global Medical Institutes, LLC Princeton New Jersey 08540 —
The Cognitive and Research Center of New Jersey (CRCNJ) Springfield New Jersey 07081 —
Advanced Memory Research Institute of NJ Toms River New Jersey 08755 —
Albany Medical Center Albany New York 12208 —
Neurological Associates of Albany Albany New York 12208 —
Integrative Clinical Trials Brooklyn New York 11229 —
SPRI Clinical Trials Brooklyn Brooklyn New York 11235 —
Velocity Clinical Research, Formerly Clarity Clinical Research East Syracuse New York 13057 —
Richmond Behavioral Associates Staten Island New York 10312 —
Accellacare Research of Winston-Salem Winston-Salem North Carolina 27103 —
Ohio State University Columbus Ohio 43210 —
Neurology Diagnostics Dayton Ohio 45459 —
Neuro-Behavioral Clinical Research (NBCR) North Canton Ohio 44720 —
Center for Cognitive Health - Portland Portland Oregon 97225 —
The Clinical Trial Center Jenkintown Pennsylvania 19046 —
Keystone Clinical Studies, LLC Plymouth Meeting Pennsylvania 19462 —
KCA Neurology, PLLC Franklin Tennessee 37067 —
Neurology Consultants of Dallas, PA Dallas Texas 75243 —
Cedar Health Research Irving Texas 75062 —
The Memory Clinic - Bennington Bennington Vermont 05201 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05026177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 22, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05026177 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →